Balovaptan
Products Balovaptan is in clinical development and is not yet commercially available. In January 2018, the compound received the FDA’s. Structure and properties Balovaptan (C22H24ClN5O, Mr = 409.9 g/mol) structurally belongs to the benzodiazepines. Effects Balovaptan improves social interaction and communication in patients with autism. The effects are due to antagonism at vasopressin-1a receptors. Vasopressin … Balovaptan
